Verastem | VSTM - Net Income

Stock Price
6.09
Daily Change
-0.44 -6.67%
Monthly
12.89%
Yearly
-13.57%
Q2 Forecast
6.44

Verastem reported $-32.92M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
AbbVie USD 1.82B 1.63B Dec/2025
Alaunos Therapeutics USD -1.16M 108K Sep/2025
AstraZeneca USD 2.33B 207M Dec/2025
Curis USD 19.36M 31.16M Dec/2025
Cytokinetics USD -183.03M 123.15M Dec/2025
Gilead Sciences USD 2.18B 869M Dec/2025
Incyte USD 299.28M 124.89M Dec/2025
Laboratory Of America USD 164.7M 96.4M Dec/2025
Novartis USD 2.41B 1.52B Dec/2025
Pfizer USD -1.65B 5.19B Dec/2025
Roche Holding CHF 5.47B 1.76B Dec/2025
TG Therapeutics USD 23.04M 367.86M Dec/2025
Verastem USD -32.92M 24.66M Dec/2025